Table 4.
Sarcopenic obesity risk prevalence.
| Diagnostic Criteria | Males, Years of Age |
Females, Years of Age |
p for Difference between Genders | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Total ≥ 65 (n = 823) |
65–74 (n = 548) |
≥75 (n = 275) |
p | Total ≥ 65 (n = 1177) |
65–74 (n = 633) |
≥75 (n = 544) |
p | ||
|
BMI ≥ 30 kg/m2
and SARC-F score ≥ 4 n(%) |
20 (2.4) | 6 (1.1) | 14 (5.1) | 0.000 | 116 (9.9) | 36 (5.7) | 80 (14.7) | 0.000 | <0.001 |
|
WC ≥ 102 (M); ≥88 (F)
and SARC-F score ≥ 4 n(%) |
31 (3.8) | 7 (1.3) | 24 (8.7) | 0.000 | 166 (14.1) | 56 (8.8) | 110 (20.2) | 0.000 | <0.001 |
| WHR ≥ 0.9 (M); ≥0.85 (F) and SARC-F score ≥ 4 n(%) | 76 (9.2) | 28 (5.1) | 48 (17.5) | 0.407 | 155 (13.2) | 54 (8.5) | 101 (18.6) | 0.41 | <0.12 |
|
WHtR > 0.5
and SARC-F score ≥ 4 n(%) |
63 (7.7) | 19 (3.5) | 44 (16.0) | 0.000 | 203 (17.2) | 69 (10.9) | 134 (24.6) | 0.000 | <0.001 |
BMI—body mass index; WC—waist circumference; WHR—waist-hip ratio; WHtR—waist to height ratio; SARC-F—simple questionnaire to rapidly diagnose sarcopenia.